AU2003225479A1 - Reporter-selectable hepatitis c virus replicon - Google Patents
Reporter-selectable hepatitis c virus repliconInfo
- Publication number
- AU2003225479A1 AU2003225479A1 AU2003225479A AU2003225479A AU2003225479A1 AU 2003225479 A1 AU2003225479 A1 AU 2003225479A1 AU 2003225479 A AU2003225479 A AU 2003225479A AU 2003225479 A AU2003225479 A AU 2003225479A AU 2003225479 A1 AU2003225479 A1 AU 2003225479A1
- Authority
- AU
- Australia
- Prior art keywords
- reporter
- hepatitis
- selectable
- virus replicon
- replicon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37566702P | 2002-04-26 | 2002-04-26 | |
| US60/375,667 | 2002-04-26 | ||
| PCT/IB2003/001687 WO2003091439A1 (en) | 2002-04-26 | 2003-04-22 | Reporter-selectable hepatitis c virus replicon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003225479A1 true AU2003225479A1 (en) | 2003-11-10 |
Family
ID=29270683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003225479A Abandoned AU2003225479A1 (en) | 2002-04-26 | 2003-04-22 | Reporter-selectable hepatitis c virus replicon |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1499727A1 (en) |
| JP (1) | JP2005523705A (en) |
| AU (1) | AU2003225479A1 (en) |
| CA (1) | CA2483513A1 (en) |
| MX (1) | MXPA04010548A (en) |
| WO (1) | WO2003091439A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007011777A2 (en) * | 2005-07-18 | 2007-01-25 | Novartis Ag | Small animal model for hcv replication |
| MX341989B (en) * | 2010-08-31 | 2016-09-09 | Novartis Ag * | Small liposomes for delivery of immunogen-encoding rna. |
| CN107475294B (en) * | 2017-08-16 | 2020-10-09 | 四川农业大学 | Preparation method of duck Tembusu reporter virus carrying Renilla luciferase, product and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5292658A (en) * | 1989-12-29 | 1994-03-08 | University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center | Cloning and expressions of Renilla luciferase |
| DE19915178A1 (en) * | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C virus cell culture system |
-
2003
- 2003-04-22 CA CA002483513A patent/CA2483513A1/en not_active Abandoned
- 2003-04-22 WO PCT/IB2003/001687 patent/WO2003091439A1/en not_active Ceased
- 2003-04-22 JP JP2003587967A patent/JP2005523705A/en active Pending
- 2003-04-22 EP EP03747188A patent/EP1499727A1/en not_active Withdrawn
- 2003-04-22 AU AU2003225479A patent/AU2003225479A1/en not_active Abandoned
- 2003-04-22 MX MXPA04010548A patent/MXPA04010548A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1499727A1 (en) | 2005-01-26 |
| JP2005523705A (en) | 2005-08-11 |
| WO2003091439A1 (en) | 2003-11-06 |
| CA2483513A1 (en) | 2003-11-06 |
| MXPA04010548A (en) | 2005-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1505963T1 (en) | Hepatitis c virus inhibitors | |
| PL371007A1 (en) | Macrocyclic peptides active against the hepatitis c virus | |
| EP1684787A4 (en) | Hepatitis c virus inhibitors | |
| EP1684745A4 (en) | Hepatitis c virus inhibitors | |
| IL174403A0 (en) | Macrocyclic peptides active against the hepatitis c virus | |
| AU2003203094A1 (en) | Computer virus control | |
| AU2003238456A1 (en) | Viral vector | |
| AU2003215806A1 (en) | Disinfectant with activity against hepatitis b virus | |
| AU2003215209A1 (en) | Syringe | |
| AU2003259457A1 (en) | Auto-destructible syringe | |
| AU2003206862A1 (en) | Hepatitis b vaccines | |
| AU2003301850A1 (en) | Hiv vaccine | |
| AU2003294757A1 (en) | Formulations useful against hepatitis c virus infections | |
| AU2003301865A1 (en) | Epitopes of hepatitis c virus | |
| AU2003230790A1 (en) | Hepatitis c virus sub-genomic replicons | |
| AU2003225479A1 (en) | Reporter-selectable hepatitis c virus replicon | |
| AU2003227026A1 (en) | An infectious bursal disease virus variant | |
| AU2003255727A1 (en) | Syringes | |
| AU2003256404A1 (en) | Hepatitis c virus assays | |
| AU2003221569A1 (en) | Cd4+ t-lymphocyte-specific hepatitis c virus epitopes | |
| AU2003272147A1 (en) | Expressional enhancers from viruses | |
| AU2003214299A1 (en) | Hiv-1 virus tat-protein mutants | |
| AU2003263028A1 (en) | Mouse hepatitis virus detection | |
| AU2006233207A1 (en) | Hepatitis C virus inhibitors | |
| AU2002351795A1 (en) | Hepatitis x virus antigen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |